Amneal Pharmaceuticals
AMRX
AMRX
140 hedge funds and large institutions have $394M invested in Amneal Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 49 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.24% less ownership
Funds ownership: 69.03% → 68.79% (-0.24%)
19% less capital invested
Capital invested by funds: $484M → $394M (-$90.5M)
20% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 49
Holders
140
Holding in Top 10
1
Calls
$1.33M
Puts
$581K
Top Buyers
| 1 | +$6.87M | |
| 2 | +$2.78M | |
| 3 | +$1.99M | |
| 4 |
MSL
Mackay Shields LLC
New York
|
+$904K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$893K |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$2.86M | |
| 3 | -$2.43M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.82M |
| 5 |
BlackRock
New York
|
-$1.4M |